About Dermazentrum Augsburg
"Die Praxis heißt jetzt »Dermazentrum Augsburg«. Alle bisherigen Leistungen werden in gewohnter Form von Dr. Rebeca Herzog und Deepashree Daulatabad Garg weiterhin angeboten. Das neue Dermazentrum deckt alle Fragen der Hautgesundheit und das gesamte Spektrum der modernen Dermatologie und Ästhetik ab. Es kommen nur moderne, schonende Therapieverfahren zum Einsatz und unsere Behandlung orientiert sich stets an den aktuellen wissenschaftlichen Erkenntnissen und technischen Möglichkeiten. Eine exzellente Behandlung aller Probleme rund um die Haut und eine menschliche Medizin – diese Grundsätze leiten uns. Wir bieten unkomplizierte und schnelle Terminvergabe für alle Kassen- und Privatpatienten. Wir freuen uns auf Sie!"
Clinical Trials at Dermazentrum Augsburg
During the past decade, Dermazentrum Augsburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Dermazentrum Augsburg"
#1 collaborator was "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Dermazentrum Augsburg
According to Clinical.Site data, the most researched conditions in "Dermazentrum Augsburg" are
"Atopic Dermatitis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Dermazentrum Augsburg" in a lesser frequency.
Clinical Trials Intervention Types at Dermazentrum Augsburg
Most popular intervention types in "Dermazentrum Augsburg" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "ABP 654" (1 trials), "Lebrikizumab" (1 trials) and "Ustekinumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dermazentrum Augsburg
The vast majority of trials in "Dermazentrum Augsburg" are
2 trials for "All" genders.
Clinical Trials Status at Dermazentrum Augsburg
Currently, there are NaN active trials in "Dermazentrum Augsburg".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Dermazentrum Augsburg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dermazentrum Augsburg, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".